Table of Contents

2019-2024 Global Fertility Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Fertility Drugs Consumption 2014-2024
  • 2.1.2 Fertility Drugs Consumption CAGR by Region
• 2.2 Fertility Drugs Segment by Type
  • 2.2.1 Gonadotropins
  • 2.2.2 Anti-Estrogens
  • 2.2.3 Other
• 2.3 Fertility Drugs Consumption by Type
  • 2.3.1 Global Fertility Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Fertility Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Fertility Drugs Sale Price by Type (2014-2019)
• 2.4 Fertility Drugs Segment by Application
  • 2.4.1 Male
  • 2.4.2 Female
• 2.5 Fertility Drugs Consumption by Application
  • 2.5.1 Global Fertility Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Fertility Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Fertility Drugs Sale Price by Application (2014-2019)

3 Global Fertility Drugs by Players

• 3.1 Global Fertility Drugs Sales Market Share by Players
  • 3.1.1 Global Fertility Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Fertility Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Fertility Drugs Revenue Market Share by Players
  • 3.2.1 Global Fertility Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Fertility Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Fertility Drugs Sale Price by Players
• 3.4 Global Fertility Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Fertility Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Fertility Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Fertility Drugs by Regions

• 4.1 Fertility Drugs by Regions
  • 4.1.1 Global Fertility Drugs Consumption by Regions
  • 4.1.2 Global Fertility Drugs Value by Regions
• 4.2 Americas Fertility Drugs Consumption Growth
• 4.3 APAC Fertility Drugs Consumption Growth
• 4.4 Europe Fertility Drugs Consumption Growth
• 4.5 Middle East & Africa Fertility Drugs Consumption Growth

5 Americas

• 5.1 Americas Fertility Drugs Consumption by Countries
  • 5.1.1 Americas Fertility Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Fertility Drugs Value by Countries (2014-2019)
• 5.2 Americas Fertility Drugs Consumption by Type
• 5.3 Americas Fertility Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Fertility Drugs Consumption by Countries
  • 6.1.1 APAC Fertility Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Fertility Drugs Value by Countries (2014-2019)
• 6.2 APAC Fertility Drugs Consumption by Type
• 6.3 APAC Fertility Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Fertility Drugs by Countries
  • 7.1.1 Europe Fertility Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Fertility Drugs Value by Countries (2014-2019)
• 7.2 Europe Fertility Drugs Consumption by Type
• 7.3 Europe Fertility Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Fertility Drugs by Countries
  • 8.1.1 Middle East & Africa Fertility Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Fertility Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Fertility Drugs Consumption by Type
• 8.3 Middle East & Africa Fertility Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Fertility Drugs Distributors
• 10.3 Fertility Drugs Customer

11 Global Fertility Drugs Market Forecast

• 11.1 Global Fertility Drugs Consumption Forecast (2019-2024)
• 11.2 Global Fertility Drugs Forecast by Regions
  • 11.2.1 Global Fertility Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Fertility Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Fertility Drugs Forecast by Type
• 11.8 Global Fertility Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Merck
  • 12.1.1 Company Details
  • 12.1.2 Fertility Drugs Product Offered
  • 12.1.3 Merck Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Merck News
• 12.2 Ferring
  • 12.2.1 Company Details
  • 12.2.2 Fertility Drugs Product Offered
  • 12.2.3 Ferring Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Ferring News
• 12.3 MSD
  • 12.3.1 Company Details
  • 12.3.2 Fertility Drugs Product Offered
  • 12.3.3 MSD Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 MSD News
• 12.4 LIVZON
  • 12.4.1 Company Details
  • 12.4.2 Fertility Drugs Product Offered
  • 12.4.3 LIVZON Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 LIVZON News
• 12.5 Abbott
  • 12.5.1 Company Details
  • 12.5.2 Fertility Drugs Product Offered
  • 12.5.3 Abbott Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Abbott News
• 12.6 Bayer
  • 12.6.1 Company Details
  • 12.6.2 Fertility Drugs Product Offered
  • 12.6.3 Bayer Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Bayer News
• 12.7 Zydus Pharma
  • 12.7.1 Company Details
  • 12.7.2 Fertility Drugs Product Offered
  • 12.7.3 Zydus Pharma Fertility Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Zydus Pharma News

...

13 Research Findings and Conclusion

Fertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

According to this study, over the next five years the Fertility Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Fertility Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Fertility Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Fertility Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Gonadotropins
Anti-Estrogens
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Male
Female

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer
Zydus Pharma
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Fertility Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Fertility Drugs market by identifying its various subsegments.
Focuses on the key global Fertility Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Fertility Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Fertility Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.